RPG Life Sciences Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
2,284.85 -17.55 (-0.76%)Updated : 16 Jan 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 432.61470.97424.84369.46
Other Net 1.15-4.800.04
Diluted Weighted Average Shares 1.651.651.651.65
Gain( Loss)on Saleof Assets 1.200.01-0.780.00
Depreciation/ Amortization 21.4317.0715.5015.66
Operating Income 220.82111.0887.9770.70
Net Income 183.2487.6667.6451.48
Income Availableto Com Excl Extra Ord 183.2487.6667.6451.48
Other Operating Expenses Total 5.145.91-3.80
Net Income Before Taxes 232.88117.8491.6873.17
Net Income After Taxes 183.2487.6667.6451.48
Income Availableto Com Incl Extra Ord 183.2487.6667.6451.48
Costof Revenue Total 241.58208.56184.52162.90
Gross Profit 411.85373.49328.29277.26
Interest Inc( Exp) Net- Non- Op Total 9.716.75-0.312.43
Unusual Expense( Income) -82.60---
Diluted Net Income 183.2487.6667.6451.48
DPS- Common Stock Primary Issue 20.0016.0012.009.60
Provisionfor Income Taxes 49.6430.1824.0421.69
period Type ----
Net Income Before Extra Items 183.2487.6667.6451.48
Total Revenue 653.43582.05512.81440.16
period Length 12.0012.0012.0012.00
Revenue 653.43582.05512.81440.16
Selling/ General/ Admin Expenses Total 247.06239.43224.82187.10
Diluted Normalized EPS 70.9253.0041.2531.13
Diluted EPS Excluding Extra Ord Items 110.7953.0040.9031.13
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,690.90+91.85(5.74%)
1,671.00+82.50(5.19%)
287.45-11.75 (-3.93%)
2,752.00-63.35 (-2.25%)